Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/31/1994 | WO1994006417A1 Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol |
03/31/1994 | WO1994006413A1 Therapeutic elevated levels of trimethylamine oxide |
03/31/1994 | WO1994006412A1 Sports drink without added sugar or artificial sweetener |
03/31/1994 | WO1994006411A1 Topical carbonic anhydrase inhibitor composition |
03/31/1994 | WO1994006405A1 Method for the treatment and/or prevention of radiation burn |
03/31/1994 | WO1994006402A2 Cosmetic or dermatologic composition containing at least one saponine of the ginsenoside type, and its applications particularly to hair care |
03/31/1994 | WO1994006296A1 Iodine/resin disinfectant and a procedure for the preparation thereof |
03/31/1994 | WO1994006280A1 Inhibitors of metazoan parasite proteases |
03/31/1994 | WO1994004122A3 Use of diacylglycerols for increasing the melanin content in melanocytes |
03/31/1994 | WO1994003421A3 Esters and combinations of an organic nitrate and a salicylate |
03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
03/31/1994 | WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
03/31/1994 | DE4303818C1 Sterile medicament for topical admin. of dexpanthenol - contg. a polyacrylate carrier to improve stability of active agent |
03/31/1994 | DE4232739A1 Neue asymmetrisch substituierte bis-Naphthalimide New asymmetrically substituted bis-naphthalimide |
03/31/1994 | DE4232414A1 Sulphonated sulphur cpds. - prepd. by sulphonating hydroxy thioether(s) and neutralising with base |
03/31/1994 | CA2145413A1 Methods and compositions for treating allergic disorders using optically pure (+) cetirizine |
03/31/1994 | CA2145412A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
03/31/1994 | CA2145410A1 Compositions for treating allergic disorders using (-) cetirizine |
03/31/1994 | CA2145206A1 1,2-disubstituted ethyl amides as inhibitors of acat |
03/31/1994 | CA2145192A1 Novel epoxide-containing compounds |
03/31/1994 | CA2145190A1 Use of taxol for treating lymphomas and breast cancer |
03/31/1994 | CA2144985A1 Thienodiazepine compounds and their pharmaceutical use |
03/31/1994 | CA2144961A1 Penem derivatives, their preparation and pharmaceutical compositions containing them |
03/31/1994 | CA2144865A1 Cosmetic or dermatologic composition containing at least one saponine of the ginsenoside type, and its applications particularly to hair care |
03/31/1994 | CA2144747A1 New natural substance cyclamenol and chemical derivatives |
03/31/1994 | CA2144659A1 Method of enhancing and/or prolonging expression of a gene introduced into a cell |
03/31/1994 | CA2144636A1 3,3'- disubstituted-1,3-dihydro-2h-pyrrolo [2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man |
03/31/1994 | CA2144545A1 Novel condensed thiazole derivative, production process thereof and pharmaceutical composition thereof |
03/31/1994 | CA2144510A1 Novel use inhibitors of phosphodiestersase iv |
03/31/1994 | CA2144419A1 Vpa-analogous antiepileptic agents |
03/31/1994 | CA2144093A1 Prostaglandin analog for treating osteoporosis |
03/31/1994 | CA2144067A1 Synthesis of n-substituted oligomers |
03/31/1994 | CA2144049A1 1,2-dihydro-3h-dibenzisoquinoline-1,3-dione anticancer agents |
03/31/1994 | CA2143333A1 Sports drink without added sugar or artificial sweetener |
03/31/1994 | CA2141879A1 Topical carbonic anhydrase inhibitor composition |
03/31/1994 | CA2122827A1 Nomegestrol derivatives-based subcutaneous implants |
03/31/1994 | CA2107010A1 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz¬cd|indoles for treating motion sickness and vomiting |
03/31/1994 | CA2107009A1 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd] indoles for treating motion sickness and vomiting |
03/31/1994 | CA2106420A1 Cigarette filter for the administration of taurine by inhalation |
03/31/1994 | CA2098446A1 2,5-dihydro-2,5-dioxo-1h-azepines and 2,5-dihydro-2-oxo-1h-azepines and the use thereof as excitatory amino acid and glycine receptor antagonists |
03/30/1994 | EP0589741A1 Use of a direct inhibitor of thrombin for the production of a drug with thrombolytic activity |
03/30/1994 | EP0589720A2 Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines |
03/30/1994 | EP0589703A1 Proline derivative of rapamycin, production and application thereof |
03/30/1994 | EP0589626A1 Preparation of beta-methyl carbapenem intermediates |
03/30/1994 | EP0589556A2 Carbohydrate-based anti-inflammatory agents |
03/30/1994 | EP0589491A1 Butenoic acid derivatives |
03/30/1994 | EP0589488A1 (-)-Cimaterol and its use as a medicament or growth promoter |
03/30/1994 | EP0589484A1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
03/30/1994 | EP0589473A1 Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and their use in pharmaceutical compositions |
03/30/1994 | EP0589446A1 N-(Hydroxyethyl)butanediamide derivatives as renin inhibitors |
03/30/1994 | EP0589445A1 Renin Inhibiting N-(2-Amino-2-oxoethyl)Butanediamide Derivatives |
03/30/1994 | EP0589428A1 Process for production of (azolylmethyl)-(biphenylmethyl)cyclopentanol derivatives |
03/30/1994 | EP0589375A1 Micronutrient compositions |
03/30/1994 | EP0589336A1 Benzoylguanidines, process for their preparation and their use as antiarrhythmic agents |
03/30/1994 | EP0589335A1 N1-Substituted- (1H)-1,2,3-Triazolo (4,5-d) pyrimidines, process for their preparation and their use as antiviral means |
03/30/1994 | EP0589330A2 NF-kappa beta antisense polynucleotides |
03/30/1994 | EP0589322A1 5-Oxo-dibenzo[a,d]cyclohepta-1,4-dienes and their use as retroviral agents |
03/30/1994 | EP0589318A2 Antibacterial 7-(aminomethyl-oxa-7-azabicyclo(3.3.0)oct-7-yl)quinolone- and -naphthyridonecarboxylic acid derivatives |
03/30/1994 | EP0589201A1 Di- and triazindeones |
03/30/1994 | EP0589069A1 Hydroquinone derivatives and antioxidants and tumor inhibitors containing them |
03/30/1994 | EP0589047A1 Method of treating infectious disease, method of preventing putrefaction of cosmetic, and antibacterial/antifungal agent and cosmetic |
03/30/1994 | EP0589038A1 Tricyclic compound |
03/30/1994 | EP0589037A1 Indian derivative and thromboxane antagonist containing the same |
03/30/1994 | EP0589034A1 METHOD FOR MAKING 3$g(a)-HYDROXY,3$g(b)-SUBSTITUTED-PREGNANES |
03/30/1994 | EP0589020A1 Ophthalmic solutions with buffer system for ocular administration |
03/30/1994 | EP0589018A1 Amines as inhibitors of squalene synthase |
03/30/1994 | EP0588994A1 FLUORESCENCE DIAGNOSTICS OF CANCER USING $g(d)-AMINO LEVULINIC ACID |
03/30/1994 | EP0588917A1 Isoxazole and isothiazole compounds that enhance cognitive function |
03/30/1994 | EP0588915A1 Azulenic retinoid compounds, compositions and methods |
03/30/1994 | EP0588914A1 Eukaryotic expression vectors with regulation of rna processing |
03/30/1994 | EP0588912A1 Blended carboxylic acid sanitizer |
03/30/1994 | EP0588881A1 3'-end blocked oligonucleotides |
03/30/1994 | EP0588859A1 Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use |
03/30/1994 | EP0588858A1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE |
03/30/1994 | EP0588857A1 Insecticide composition. |
03/30/1994 | EP0588852A1 Immunosuppressive and tolerogenic oligosaccharide derivatives |
03/30/1994 | EP0588848A1 Modified sialyl lewis?a compounds |
03/30/1994 | EP0588839A1 Nitroglycerine plaster and process for making it. |
03/30/1994 | EP0588796A1 New compounds and compositions useful as antifungal and antimycobacterial agents |
03/30/1994 | EP0588785A1 Urea based lipoxygenase inhibiting compounds |
03/30/1994 | EP0445258B1 5'-alkylphosphonylnucleosides as antivirals |
03/30/1994 | EP0342211B1 Treatment of arteriosclerosis by administration of l-tryptophan or l-5-hydroxytryptophan |
03/30/1994 | EP0118567B1 Process for the preparationof 2-substituted cephem derivatives |
03/30/1994 | CN1084564A Antisense polynucleotides |
03/30/1994 | CN1084516A Azacyclic and azabicyclic alkyliden hydroxylamines |
03/30/1994 | CN1084515A Phenyl sulfonamide endothelin antagonists |
03/30/1994 | CN1084509A Cancer sensitizing drug butyl sulfanilic acid and preparing method thereof |
03/30/1994 | CA2107026A1 Pharmaceutical compositions containing 1,5,6,7-tetrahydro-4h-indazol-4-ones, new 1,5,6,7-tetrahydro-4h-indazol-4-ones and processes for preparing them |
03/30/1994 | CA2106917A1 17-aryl and 17-heterocyclyl-5.beta.,14.beta.-androstane, derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
03/30/1994 | CA2106916A1 17-aryl and 17-heterocyclyl-14.beta.-5.alpha.-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
03/29/1994 | US5298647 Aromatic compounds of amide structure derived from aminobenzoic acids, hydroxy-benzoic acids, cinnamic acids, urocanic acids and benzimidazoles, absorbing UVB and/or UVA |
03/29/1994 | US5298627 Anticholesterol, hypolipidemic agents, enzyme inhibitors |
03/29/1994 | US5298626 4-methyl-3-(2propynyl)amino-1,2,3,4 -tetrahydrocyclopenta(b)-indole-7-yl methylcarbamate |
03/29/1994 | US5298616 Oligosaccharide contains a maximum of 6 monosaccharide units and at least one metal-sulfonate per monosaccharide unit |
03/29/1994 | US5298525 Diabetes prevention and treatment |
03/29/1994 | US5298523 Method for treating transplant patients using mycalamide compounds |
03/29/1994 | US5298522 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
03/29/1994 | US5298520 Analgesics for treatment of migraine as antagonists for 5-HT1 receptors |
03/29/1994 | US5298519 Acylals of imidazole-5-carboxylic acid derivatives, and their use as angiotensin (II) inhibitors |
03/29/1994 | US5298516 Treatment of cardiovascular disorders, angina |